Managing fungal and viral infections in pediatric leukemia (Q37810281)

23 August 2017

Managing fungal and viral infections in pediatric leukemia (English)

1 reference

23 August 2017

1 reference

Hana Hakim

1

1 reference

PubMed ID

21083477

23 August 2017

Jerry L Shenep

series ordinal

2

1 reference

23 August 2017

1 October 2010

1 reference

Expert Review of Hematology

23 August 2017

1 reference

23 August 2017

3

1 reference

23 August 2017

603-624

1 reference

23 August 2017

5

1 reference

Treatment of acute lymphoblastic leukemia

23 August 2017

1 reference

Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.

21 January 2018

1 reference

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93

21 January 2018

1 reference

Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group

21 January 2018

1 reference

Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis

21 January 2018

1 reference

Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia

21 January 2018

1 reference

The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.

21 January 2018

1 reference

Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival

21 January 2018

1 reference

Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: A 13-year experience at a single Italian institution

21 January 2018

1 reference

Fungal Infections in Children With Cancer

21 January 2018

1 reference

Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution.

21 January 2018

1 reference

A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation

21 January 2018

1 reference

Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland

21 January 2018

1 reference

Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia

21 January 2018

1 reference

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

21 January 2018

1 reference

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection

21 January 2018

1 reference

Zygomycetes infections in pediatric hematology oncology patients: a case series and review of the literature.

21 January 2018

1 reference

Fungal infections in oncology patients: update on epidemiology, prevention, and treatment

21 January 2018

1 reference

21 January 2018

Emerging fungal diseases

1 reference

Changing epidemiology of rare mould infections: implications for therapy

21 January 2018

1 reference

Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis

21 January 2018

1 reference

Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL.

21 January 2018

1 reference

Significance of oral Candida infections in children with cancer.

21 January 2018

1 reference

Risk factors for disseminated candidiasis in children with candidemia

21 January 2018

1 reference

Candida infective endocarditis: report of 15 cases from a prospective multicenter study.

21 January 2018

1 reference

Use of abdominal computed tomography for identifying disseminated fungal infection in pediatric cancer patients

21 January 2018

1 reference

Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis

21 January 2018

1 reference

Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment

21 January 2018

1 reference

Hepatosplenic candidiasis in patients with acute leukaemia

21 January 2018

1 reference

Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature

21 January 2018

1 reference

Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi

21 January 2018

1 reference

Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.

21 January 2018

1 reference

Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report

21 January 2018

1 reference

Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection.

21 January 2018

1 reference

Fusarium infection in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

Fusarium infections in immunocompromised patients

21 January 2018

1 reference

Zygomycosis in children: a systematic review and analysis of reported cases

21 January 2018

1 reference

Successful treatment of mucor infection after liver or pancreas-kidney transplantation.

21 January 2018

1 reference

Rhinocerebral zygomycosis in childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

Epidemiology of invasive mycoses in North America

21 January 2018

1 reference

Infections caused by Scedosporium spp.

21 January 2018

1 reference

Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006.

21 January 2018

1 reference

Histoplasmosis in a pediatric oncology center

21 January 2018

1 reference

Endemic mycoses: blastomycosis, histoplasmosis, and sporotrichosis

21 January 2018

1 reference

Role of flexible bronchoscopy in the diagnosis of pulmonary infiltrates in pediatric patients with cancer.

21 January 2018

1 reference

Reversed halo sign in invasive pulmonary fungal infections.

21 January 2018

1 reference

Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases

21 January 2018

1 reference

Appearances of paranasal fungal sinusitis on computed tomography

21 January 2018

1 reference

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

21 January 2018

1 reference

Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders

21 January 2018

1 reference

Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders

21 January 2018

1 reference

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

21 January 2018

1 reference

Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients

21 January 2018

1 reference

Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections

21 January 2018

1 reference

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

21 January 2018

1 reference

1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.

21 January 2018

1 reference

Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials

21 January 2018

1 reference

Pseudomonas aeruginosa as a cause of 1,3-beta-D-glucan assay reactivity

21 January 2018

1 reference

Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting

21 January 2018

1 reference

High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease

21 January 2018

1 reference

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

21 January 2018

1 reference

Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.

21 January 2018

1 reference

Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study

21 January 2018

1 reference

Anidulafungin versus fluconazole for invasive candidiasis

21 January 2018

1 reference

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.

21 January 2018

1 reference

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

21 January 2018

1 reference

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin

21 January 2018

1 reference

Pneumocystis pneumonia in children

21 January 2018

1 reference

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

21 January 2018

1 reference

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

21 January 2018

1 reference

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

21 January 2018

1 reference

In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest

21 January 2018

1 reference

Activity of posaconazole in treatment of experimental disseminated zygomycosis.

21 January 2018

1 reference

In vitro susceptibilities of zygomycetes to conventional and new antifungals

21 January 2018

1 reference

Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice

21 January 2018

1 reference

Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice

21 January 2018

1 reference

Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.

21 January 2018

1 reference

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

21 January 2018

1 reference

Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment

21 January 2018

1 reference

Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse

21 January 2018

1 reference

The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer

21 January 2018

1 reference

Interferon-gamma therapy in two patients with progressive chronic pulmonary aspergillosis.

21 January 2018

1 reference

Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.

21 January 2018

1 reference

The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation

21 January 2018

1 reference

Efficacy and safety of G-CSF mobilized granulocyte transfusions in four neutropenic children with sepsis and invasive fungal infection

21 January 2018

1 reference

Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia

21 January 2018

1 reference

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

21 January 2018

1 reference

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

21 January 2018

1 reference

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies

21 January 2018

1 reference

Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials

21 January 2018

1 reference

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis

21 January 2018

1 reference

Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies

21 January 2018

1 reference

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

21 January 2018

1 reference

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence.

21 January 2018

1 reference

Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands.

21 January 2018

1 reference

Risk factors for breakthrough invasive fungal infection during secondary prophylaxis

21 January 2018

1 reference

Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients

21 January 2018

1 reference

Few but severe viral infections in children with cancer: a prospective RT-PCR and PCR-based 12-month study.

21 January 2018

1 reference

Etiology and clinical course of febrile neutropenia in children with cancer

21 January 2018

1 reference

Respiratory viral infections in children with leukemia.

21 January 2018

1 reference

Respiratory virus infections in children with cancer or HIV infection

21 January 2018

1 reference

Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age.

21 January 2018

1 reference

Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients

21 January 2018

1 reference

Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature

21 January 2018

1 reference

Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors

21 January 2018

1 reference

Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient

21 January 2018

1 reference

Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy

21 January 2018

1 reference

Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses.

21 January 2018

1 reference

Duration of influenza A virus shedding in hospitalized patients and implications for infection control

21 January 2018

1 reference

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

21 January 2018

1 reference

Morbidity of pandemic H1N1 influenza in children with cancer

21 January 2018

1 reference

H1N1 novel influenza A in pregnant and immunocompromised patients.

21 January 2018

1 reference

2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients.

21 January 2018

1 reference

Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts

21 January 2018

1 reference

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

21 January 2018

1 reference

Newly discovered respiratory viruses: significance and implications

21 January 2018

1 reference

Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin

21 January 2018

1 reference

Human metapneumovirus infection in a hematopoietic transplant recipient

21 January 2018

1 reference

Cloning of a human parvovirus by molecular screening of respiratory tract samples

21 January 2018

1 reference

Human bocavirus: passenger or pathogen in acute respiratory tract infections?

21 January 2018

1 reference

Human bocavirus in children with acute lymphoblastic leukemia.

21 January 2018

1 reference

Human bocavirus infections in hospitalized children and adults

21 January 2018

1 reference

Palivizumab prophylaxis to prevent respiratory syncytial virus mortality after pediatric bone marrow transplantation: a decision analysis model.

21 January 2018

1 reference

Interventions for prevention and treatment of herpes simplex virus in cancer patients

21 January 2018

1 reference

Antiviral prophylaxis in haematological patients: systematic review and meta-analysis

21 January 2018

1 reference

Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia

21 January 2018

1 reference

Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study

21 January 2018

1 reference

Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection

21 January 2018

1 reference

Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection

21 January 2018

1 reference

Fatal adenovirus hepatitis during standard chemotherapy for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease.

21 January 2018

1 reference

Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

21 January 2018

1 reference

Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient.

21 January 2018

1 reference

Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy

21 January 2018

1 reference

Parvovirus B19 infection in pediatric oncology patients: diagnostic value of clinical and serologic parameters compared with nested PCR.

21 January 2018

1 reference

Parvovirus B19 infection as a cause of anemia in pediatric acute lymphoblastic leukemia patients during maintenance chemotherapy

21 January 2018

1 reference

BK virus-induced tubulointerstitial nephritis in a child with acute lymphoblastic leukemia

21 January 2018

1 reference

BK virus nephropathy in an immunodeficient patient with chronic lymphocytic leukemia

21 January 2018

1 reference

BK virus-associated hemorrhagic cystitis in pediatric cancer patients receiving high-dose cyclophosphamide

21 January 2018

1 reference

A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation

21 January 2018

1 reference

BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients

21 January 2018

1 reference

BK virus infection in hematopoietic stem cell transplant recipients: frequency, risk factors, and association with postengraftment hemorrhagic cystitis

21 January 2018

1 reference

Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study

21 January 2018

1 reference

Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant

21 January 2018

1 reference

Antiviral therapy for polyomavirus-associated nephropathy after renal transplantation

21 January 2018

1 reference

Leflunomide for polyomavirus type BK nephropathy

21 January 2018

1 reference

Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review

21 January 2018

1 reference

Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination

21 January 2018

1 reference

Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia.

21 January 2018

1 reference

Unexpected protection from infection by two booster hepatitis B virus vaccination in children with acute lymphoblastic leukemia

21 January 2018

1 reference

Invasive pulmonary aspergillosis in neutropenic patients and the influence of hospital renovation.

21 January 2018

1 reference

Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation.

21 January 2018

1 reference

Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies.

21 January 2018

1 reference

Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters

21 January 2018

1 reference

Positive-pressure isolation and the prevention of invasive aspergillosis. What is the evidence?

21 January 2018

1 reference

Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America

21 January 2018

1 reference

Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America

21 January 2018

1 reference

Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis

21 January 2018

1 reference

Galactomannan in Bronchoalveolar Lavage Fluid

21 January 2018

1 reference

Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant

21 January 2018

1 reference

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1086/422009

Identifiers

DOI

10.1586/EHM.10.58

1 reference

23 August 2017

1 reference

PubMed ID

21083477